Maybe it's time to give your portfolio a dose of pharmaceutical stocks.
The sector has taken a beating lately with the NYSE Arca Pharmaceutical Indexdown around 10% in the three months through Friday, while the Market Vectors Pharmaceutical exchange-traded fund (PPH) , which tracks the sector, was off 13% in the same period. The S&P 500 Index was down 1% over that time span.
At least part of the selloff was a media circus that erupted when one company raised the price of an HIV drug by 5,000% and Democratic presidential candidate Hillary Clinton weighed in on the topic. What it means is that the sector is getting a lot of unwanted (and perhaps in some cases, unwarranted) attention, which adds to concerns about government interference in the industry. That, in turn, is making the stockholders nervous. Read more here.
No comments:
Post a Comment